Improved OS Data Signal New Era With Immunotherapy in Small Cell Lung Cancer

After decades of minimal progress, recent regulatory updates with checkpoint inhibitors have sparked excitement in extensive-stage small cell lung cancer (ES-SCLC) treatment, said Lawrence E. Feldman, MD.
... to read the full story